GlassScriptPhysician profile
Stanley Earl Scheidler
NPI 1548243900
$22,231.44
in general payments reported to CMS, 2019-2025
75 companies · $3,481 in 2025
The $3,481 reported for 2025 was more than what 98% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,002 · 2020: $2,198 · 2021: $3,578 · 2022: $2,348 · 2023: $3,258 · 2024: $3,367 · 2025: $3,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,084.84 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,581.91 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $2,304.69 | 2019-2025 | Vraylar, Mavyret, Ubrelvy |
| Astellas Pharma US INC | $1,212.41 | 2019-2024 | Veozah, Myrbetriq |
| Alkermes, INC. | $1,146.96 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Novo Nordisk INC | $1,031.04 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $992.97 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Bayer Healthcare Pharmaceuticals INC. | $988.27 | 2021-2025 | |
| Amgen INC. | $968.28 | 2019-2025 | Otezla, Repatha, Repatha |
| Otsuka America Pharmaceutical, INC. | $779.78 | 2021-2025 | Rexulti |
| Pfizer INC. | $768.53 | 2019-2025 | |
| Grifols USA, LLC | $671.31 | 2019-2025 | Prolastin-C Liquid |
| Allergan, INC. | $499.23 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $486.24 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $486.11 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $485.78 | 2019-2024 | Spravato |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $481.03 | 2019-2023 | Qelbree |
| Abbott Laboratories | $466.97 | 2020-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $420.28 | 2023-2025 | Caplyta |
| Novartis Pharmaceuticals Corporation | $360.71 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $330.94 | 2019-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $329.84 | 2024-2025 | Fanapt, Hetlioz |
| Sanofi-Aventis U.S. LLC | $320.16 | 2019-2021 | |
| Exact Sciences Corporation | $287.76 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $256.45 | 2019-2024 | Xifaxan |
| Glaxosmithkline, LLC. | $230.60 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Sumitomo Pharma America, INC. | $224.48 | 2024-2025 | Gemtesa |
| Amarin Pharma, INC. | $222.01 | 2019-2020 | |
| Indivior INC. | $217.69 | 2019-2025 | Sublocade |
| Dexcom, INC. | $206.86 | 2024-2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $202.45 | 2023-2025 | Rexulti, Vyepti |
| Gilead Sciences, INC. | $174.17 | 2021-2024 | |
| Antares Pharma, INC. | $174.10 | 2019-2025 | Xyosted |
| Mylan Specialty L.P. | $169.88 | 2023-2024 | Yupelri |
| Xeris Pharmaceuticals, INC. | $161.31 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Renalytix Ai, INC. | $151.94 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Nestle Healthcare Nutrition INC. | $110.06 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $100.52 | 2019-2025 | |
| Braeburn INC. | $78.86 | 2023-2024 | Brixadi |
| Eisai INC. | $77.12 | 2020-2022 | |
| Axsome Therapeutics, INC. | $70.81 | 2023-2025 | Auvelity |
| Mdd US Operations, LLC | $65.60 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $64.81 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Daiichi Sankyo INC. | $64.65 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $62.53 | 2020-2022 | |
| Horizon Therapeutics Plc | $48.85 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $46.73 | 2019-2020 | |
| Almatica Pharma LLC | $40.43 | 2022 | |
| Esperion Therapeutics, INC. | $39.17 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $37.47 | 2019-2023 | Seglentis |
| Ironwood Pharmaceuticals, INC | $36.11 | 2020-2021 | |
| Insulet Corporation | $33.34 | 2019-2025 | Omnipod |
| Medtronic, INC. | $29.31 | 2022 | |
| Radius Health, INC. | $29.04 | 2019-2025 | Tymlos |
| Verona Pharma, INC. | $28.67 | 2025 | Ohtuvayre |
| Shire North American Group INC | $26.13 | 2019 | |
| Madrigal Pharmaceuticals | $25.71 | 2025 | Rezdiffra |
| Hikma Pharmaceuticals USA | $25.68 | 2019 | |
| Corcept Therapeutics | $24.18 | 2025 | Korlym |
| Ibsa Pharma INC. | $23.90 | 2024 | Licart, Tirosint |
| Nevro Corp. | $21.96 | 2022 | |
| Echosens North America, INC. | $20.35 | 2025 | Fibroscan |
| Phathom Pharmaceuticals, INC. | $18.65 | 2024 | Voquezna |
| Viatris Specialty LLC | $17.07 | 2025 | Yupelri |
| Qol Medical, LLC | $15.64 | 2021 | |
| Clarus Therapeutics INC. | $15.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.25 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.97 | 2023 | Quviviq |
| Tris Pharma INC | $14.94 | 2025 | Dyanavel Xr |
| Evoke Pharma, INC. | $14.78 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.79 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $13.69 | 2025 | |
| Hologic Sales and Service, LLC | $13.28 | 2024 | Thinprep 2000 Processor, Aptima |
| Impel Pharmaceuticals INC. | $13.28 | 2023 | Trudhesa |
| Redhill Biopharma INC. | $12.97 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
Breztri $779Kerendia $761Verquvo $758Rexulti $753Vraylar $674Farxiga $635Airsupra $630Aristada $594Caplyta $420Ozempic $408Rybelsus $371Ubrelvy $355Fanapt $330Prolastin-C Liquid $314Qulipta $302Mavyret $250Cologuard Collection Kit $242Nurtec Odt $232Gemtesa $224Hetlioz $220Trelegy Ellipta $213Dexcom G6 Transmitter $207Andexxa $202Yupelri $187Veozah $170Zavzpret $165Vivitrol $163Jardiance $155Xyosted $152Belsomra $151Lybalvi $148Otezla $143Mounjaro $138Xifaxan $133Repatha $128Freestyle Libre 3 $119Freestyle Libre 2 $106Kidneyintelx Blood Collection Convenience Kit $103Vyepti $98.78Spravato $94.03Gvoke Hypopen $89.59Qelbree $84.22Brixadi $78.86Zepbound $77.17Entresto $74.67Leqvio $74.67Auvelity $70.81T:Slim X2 Insulin Pump With Control-Iq $64.81Myrbetriq $64.23Wegovy $62.20Steglatro $55.64Eliquis $53.84Botox $47.70Trintellix $46.47The Cologuard Plus Collection Kit $46.22Sublocade $37.74Ohtuvayre $28.67Zenpep $27.88Rezdiffra $25.71Korlym $24.18Tirosint $23.90Licart $23.90Fibroscan $20.35Voquezna $18.65Ztlido $18.64Arexvy $17.15Recorlev $16.00Quviviq $14.97Dyanavel Xr $14.94Gimoti $14.78Tymlos $14.75Omnipod $14.34Enbrel $14.28Seglentis $14.00Aptima $13.28Thinprep 2000 Processor $13.28Trudhesa $13.28Comirnaty $13.04Paxlovid $13.04Linzess $8.49
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Scheidler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.